1. Takeda N, Maemura K, Nagai R et al. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res. 2004;95(2):146–53.
2. Takeda N, et al. Differential activation and antagonistic function of HIF- isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010;24(5):491–501.
3. Saito T, Takeda N*, Maemura K et al. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing. FEBS Lett. 2013;587(14):2179–85.
4. Cowburn AS, Takeda N, et al. HIF isoforms in the skin differentially regulate systemic arterial pressure. Proc Natl Acad Sci U S A. 2013;110(43):17570–5.
5. Semba H, Takeda N*, Komuro I et al. HIF-1-PDK1 axis induced active glycolysis plays an essential role in macrophage migratory capacity. Nat Commun. 2016;7:11635.
6. Krzywinska E, Takeda N, et al. Loss of HIF-1α in Natural Killer cells inhibits tumour growth by stimulating non-productive angiogenesis. Nat Commun. 2017;8:1597.
7. Goodwin J, Takeda N, et al. Targeting HIF-1α/PDK1 axis by dichloroacetate (DCA) suppresses bleomycin-induced pulmonary fibrosis.
Am J Respir Cell Mol Biol. 2018;58(2):216–231.
8. Nakagama Y, Inuzuka R, Takeda N, et al. Accelerated cardiomyocyte proliferation in the heart of a neonate with LEOPARD syndrome-associated fatal cardiomyopathy.
Circ Heart Fail. 2018;11(4):e004660.
9. Matsumoto L, Hirota Y, Takeda N, et al. HIF2α in the uterine stroma permits embryo invasion and luminal epithelium detachment. J Clin Invest. 2018;128(7):3186-3197.
10. Minatsuki S, Takeda N*, Soma K, et al. Murine model of pulmonary artery overflow vasculopathy revealed macrophage accumulation in the lung. Int Heart J. 2019 (in press).